MacroGenics (MGNX) PT Lowered to $6 at Stifel
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
MacroGenics (MGNX) PT Lowered to $5 at BMO Capital
August 7, 2024 9:23 AM EDTBMO Capital analyst Etzer Darout lowered the price target on MacroGenics (NASDAQ: MGNX) to $5.00 (from $8.00) while maintaining a Market Perform rating.
The analyst commented, "MGNX's 2Q update was in line with our expectations following the vobra duo (BH3 ADC) news last... More
Macrogenics (MGNX) Misses Q2 EPS by 23c
August 6, 2024 4:52 PM EDTMacrogenics (NASDAQ: MGNX) reported Q2 EPS of ($0.89), $0.23 worse than the analyst estimate of ($0.66). Revenue for the quarter came in at $10.79 million versus the consensus estimate of $20.94 million.
For earnings history and earnings-related data on Macrogenics (MGNX) click here.
... More